166 related articles for article (PubMed ID: 34638339)
1. Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer Cells.
Heiserman JP; Nallanthighal S; Gifford CC; Graham K; Samarakoon R; Gao C; Sage JJ; Zhang W; Higgins PJ; Cheon DJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638339
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer.
Nallanthighal S; Rada M; Heiserman JP; Cha J; Sage J; Zhou B; Yang W; Hu Y; Korgaonkar C; Hanos CT; Ashkavand Z; Norman K; Orsulic S; Cheon DJ
Cell Death Dis; 2020 Apr; 11(4):258. PubMed ID: 32312965
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract][Full Text] [Related]
4. Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines.
Heiserman JP; Minhas Z; Nikpayam E; Cheon DJ
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628819
[TBL] [Abstract][Full Text] [Related]
5. Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies.
Wantoch von Rekowski K; König P; Henze S; Schlesinger M; Zawierucha P; Januchowski R; Bendas G
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287446
[TBL] [Abstract][Full Text] [Related]
6. Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.
Wu YH; Huang YF; Chang TH; Chou CY
Int J Cancer; 2017 Dec; 141(11):2305-2317. PubMed ID: 28815582
[TBL] [Abstract][Full Text] [Related]
7. Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression.
Wu YH; Huang YF; Chen CC; Chou CY
Cell Death Dis; 2019 Apr; 10(4):322. PubMed ID: 30975980
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
Zhang Y; Shen X
Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
[TBL] [Abstract][Full Text] [Related]
9. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.
Wu YH; Chang TH; Huang YF; Chen CC; Chou CY
Oncotarget; 2015 Sep; 6(27):23748-63. PubMed ID: 26087191
[TBL] [Abstract][Full Text] [Related]
10. HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells.
Lu H; Sun C; Zhou T; Zhou B; Guo E; Shan W; Xia M; Li K; Weng D; Meng L; Xu X; Hu J; Ma D; Chen G
Oncol Res; 2016; 23(3):119-28. PubMed ID: 26931434
[TBL] [Abstract][Full Text] [Related]
11. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
12. miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.
Wu YH; Huang YF; Chang TH; Wu PY; Hsieh TY; Hsiao SY; Huang SC; Chou CY
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944877
[TBL] [Abstract][Full Text] [Related]
13. Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer.
Nallanthighal S; Heiserman JP; Cheon DJ
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668097
[TBL] [Abstract][Full Text] [Related]
14. Activation of COL11A1 by PRRX1 promotes tumor progression and radioresistance in ovarian cancer.
Zhu M; Ye C; Wang J; Yang G; Ying X
Int J Radiat Biol; 2021; 97(7):958-967. PubMed ID: 33970764
[TBL] [Abstract][Full Text] [Related]
15. Collagen XI alpha 1 chain, a potential therapeutic target for cancer.
Liu Z; Lai J; Jiang H; Ma C; Huang H
FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448
[TBL] [Abstract][Full Text] [Related]
16. Heat Shock Protein 27, a Novel Regulator of Transforming Growth Factor β Induced Resistance to Cisplatin in A549 Cell.
Huang Z; Yang C; Sun S; Nan Y; Lang Z; Wang X; Zhao J; Liu Y
Pharmacology; 2017; 100(5-6):283-291. PubMed ID: 28848138
[TBL] [Abstract][Full Text] [Related]
17. The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.
Liu CL; Chen SF; Wu MZ; Jao SW; Lin YS; Yang CY; Lee TY; Wen LW; Lan GL; Nieh S
Oncotarget; 2016 Mar; 7(12):14279-90. PubMed ID: 26872057
[TBL] [Abstract][Full Text] [Related]
18. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
19. The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function.
Wang H; Ren R; Yang Z; Cai J; Du S; Shen X
J Cancer; 2021; 12(5):1406-1420. PubMed ID: 33531986
[TBL] [Abstract][Full Text] [Related]
20. Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment.
Wu YH; Chou CY
Front Oncol; 2022; 12():925165. PubMed ID: 35847935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
